ID

12246

Beschrijving

An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients NCT00090051 Roche BO17072

Trefwoorden

  1. 01-10-15 01-10-15 -
  2. 28-10-15 28-10-15 -
  3. 28-10-15 28-10-15 -
Geüploaded op

28 oktober 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

CLL Pharmacokinetics BO17072 NCT00090051

Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

Blood sampling for pharmacokinetics (Rituximab)
Beschrijving

Blood sampling for pharmacokinetics (Rituximab)

Scheduled sampling time
Beschrijving

Scheduled sampling time

Datatype

time

Maateenheden
  • h
Alias
UMLS CUI [1]
C0040223
h
Scheduled sampling date
Beschrijving

Scheduled sampling date

Datatype

date

Maateenheden
  • dd/mm/yy
Alias
UMLS CUI [1]
C0011008
dd/mm/yy
Sample number
Beschrijving

Sample number

Datatype

integer

Alias
UMLS CUI [1]
C1299222
Sample collection date
Beschrijving

Sample collection date

Datatype

date

Maateenheden
  • dd/mm/yy
Alias
UMLS CUI [1]
C1549498
dd/mm/yy
Sample collection time
Beschrijving

Sample collection time

Datatype

time

Maateenheden
  • hh:mm
Alias
UMLS CUI [1]
C0427352
hh:mm
Remarks
Beschrijving

Remarks

Datatype

text

Alias
UMLS CUI [1]
C0947611
If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
Beschrijving

If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.

Scheduled sampling time
Beschrijving

After the end of infusion

Datatype

time

Maateenheden
  • h
Alias
UMLS CUI [1]
C0040223
h
Sampling number
Beschrijving

Sampling number

Datatype

integer

Alias
UMLS CUI [1]
C1299222
Sample collection date
Beschrijving

Sample collection date

Datatype

date

Maateenheden
  • dd/mm/yy
Alias
UMLS CUI [1]
C1549498
dd/mm/yy
Sample collection time
Beschrijving

Sample collection time

Datatype

time

Maateenheden
  • hh:mm
Alias
UMLS CUI [1]
C0427352
hh:mm
Remarks
Beschrijving

Remarks

Datatype

text

Alias
UMLS CUI [1]
C0947611

Similar models

Pharmacokinetics Cycle 1 and 3 of Chronic lymphocytic leukemia NCT0090051

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Blood sampling for pharmacokinetics (Rituximab)
Scheduled sampling time
Item
Scheduled sampling time
time
C0040223 (UMLS CUI [1])
Scheduled sampling date
Item
Scheduled sampling date
date
C0011008 (UMLS CUI [1])
Sample number
Item
Sample number
integer
C1299222 (UMLS CUI [1])
Sample collection date
Item
Sample collection date
date
C1549498 (UMLS CUI [1])
Sample collection time
Item
Sample collection time
time
C0427352 (UMLS CUI [1])
Remarks
Item
Remarks
text
C0947611 (UMLS CUI [1])
Item Group
If patient takes Rituximab on day 1, then start of Fludarabine and Cyclophosphamide pharmacokinetic sampling starts on day 2, immediately prior the infusion.
Scheduled sampling time
Item
Scheduled sampling time
time
C0040223 (UMLS CUI [1])
Sampling number
Item
Sampling number
integer
C1299222 (UMLS CUI [1])
Sample collection date
Item
Sample collection date
date
C1549498 (UMLS CUI [1])
Sample collection time
Item
Sample collection time
time
C0427352 (UMLS CUI [1])
Remarks
Item
Remarks
text
C0947611 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial